Found: 18
Select item for more details and to access through your institution.
Translational model of melphalan-induced gut toxicity reveals drug-host-microbe interactions that drive tissue injury and fever.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 173, doi. 10.1007/s00280-021-04273-7
- By:
- Publication type:
- Article
Population pharmacokinetics and exposure–response of selumetinib and its N‐desmethyl metabolite in pediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 189, doi. 10.1007/s00280-021-04274-6
- By:
- Publication type:
- Article
Tissue distribution of epirubicin after severe extravasation in humans.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 203, doi. 10.1007/s00280-021-04280-8
- By:
- Publication type:
- Article
Time-dependent population PK models of single-agent atezolizumab in patients with cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 211, doi. 10.1007/s00280-021-04276-4
- By:
- Publication type:
- Article
Downregulation of SELENBP1 enhances oral squamous cell carcinoma chemoresistance through KEAP1–NRF2 signaling.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 223, doi. 10.1007/s00280-021-04284-4
- By:
- Publication type:
- Article
Glaucocalyxin A induces apoptosis and autophagy in tongue squamous cell carcinoma cells by regulating ROS.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 235, doi. 10.1007/s00280-021-04285-3
- By:
- Publication type:
- Article
Population pharmacokinetic model of irinotecan and its four main metabolites in patients treated with FOLFIRI or FOLFIRINOX regimen.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 247, doi. 10.1007/s00280-021-04255-9
- By:
- Publication type:
- Article
Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 259, doi. 10.1007/s00280-021-04278-2
- By:
- Publication type:
- Article
No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 271, doi. 10.1007/s00280-021-04281-7
- By:
- Publication type:
- Article
Exploratory analysis of target concentration of lenvatinib in the treatment of hepatocellular carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 281, doi. 10.1007/s00280-021-04286-2
- By:
- Publication type:
- Article
NCTR25 fusion facilitates the formation of TRAIL polymers that selectively activate TRAIL receptors with higher potency and efficacy than TRAIL.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 289, doi. 10.1007/s00280-021-04283-5
- By:
- Publication type:
- Article
An exploration of the impact of ethanol diluent on breath alcohol concentration in patients receiving paclitaxel chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 307, doi. 10.1007/s00280-021-04279-1
- By:
- Publication type:
- Article
Influence of genetic variants in asparaginase pathway on the susceptibility to asparaginase-related toxicity and patients' outcome in childhood acute lymphoblastic leukemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 313, doi. 10.1007/s00280-021-04290-6
- By:
- Publication type:
- Article
Autophagy inhibitor potentiates the antitumor efficacy of apatinib in uterine sarcoma by stimulating PI3K/Akt/mTOR pathway.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 323, doi. 10.1007/s00280-021-04291-5
- By:
- Publication type:
- Article
Phase 1 study of alisertib (MLN8237) and weekly irinotecan in adults with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 335, doi. 10.1007/s00280-021-04293-3
- By:
- Publication type:
- Article
MiRNA-3662 reverses the gemcitabine resistance in pancreatic cancer through regulating the tumor metabolism.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 343, doi. 10.1007/s00280-021-04289-z
- By:
- Publication type:
- Article
Toxicity and pharmacokinetics of actinomycin-D and vincristine in children and adolescents: Children's Oncology Group Study ADVL06B1.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 359, doi. 10.1007/s00280-021-04295-1
- By:
- Publication type:
- Article
Correction to: Apoptosis of murine melanoma B16-BL6 cells induced by quercetin targeting mitochondria, inhibiting expression of PKC-α and translocating PKC-δ.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice